Wedbush: Regulus Therapeutics Will Quadruple In Price Within 12 Months

By: via Benzinga
Shares of Regulus Therapeutics Inc (NASDAQ: RGLS) were down almost 6 percent on Thursday, following the announcement that dosing has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.